Inhibitor Classification
Inhibitor Classification is a systematic framework in pharmacological research that categorizes cytochrome P450 inhibitors based on their mechanistic properties, potency, and specificity to distinguish their biochemical interactions and predict drug-drug interaction risks.
635
Publications
32.9K
Citations
4.8K
Authors
843
Institutions
Publications per year
2017–2026
134
Parents
635
The specificities of protein kinase inhibitors: an update
Jenny Bain, Hilary McLauchlan, Matthew Elliott et al. · Biochemical Journal · 2003 · 1.4K citations · Full text
Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 784 citations
1–5 of 635
4.8K
11
h-index
9
h-index
7
h-index
6
h-index
6
h-index
1–5 of 4.8K
843
Pfizer (United States)
New York, United States
19 h-index
266 publications
17.5K citations
Bristol-Myers Squibb (United States)
New York, United States
12 h-index
153 publications
8.7K citations

Centre National de la Recherche Scientifique
Paris, France
12 h-index
56 publications
3.1K citations

Chinese Academy of Sciences
Beijing, China
11 h-index
74 publications
2.3K citations
Amgen (United States)
Thousand Oaks, United States
11 h-index
206 publications
10.4K citations

Saarland University
Saarbrücken, Germany
11 h-index
55 publications
3.1K citations
Shanghai Institute of Materia Medica
Pudong, China
11 h-index
59 publications
1.7K citations

GlaxoSmithKline (United Kingdom)
London, United Kingdom
10 h-index
137 publications
5.3K citations
1–8 of 843
112 publications · 6.8K citations
52
h-index
99 publications · 3.8K citations
36
h-index
42 publications · 1.7K citations
24
h-index
30 publications · 1K citations
21
h-index
20 publications · 962 citations
17
h-index
1–5